LABP Company Profile and Key Details
Landos Biopharma, Inc.
LABP Stock Price Chart
Stock Price Today
Landos Biopharma, Inc. (LABP) stock surged +0.57%, trading at $22.93 on NASDAQ, up from the previous close of $22.80. The stock opened at $22.93, fluctuating between $22.75 and $22.94 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1 (NOD-like), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and LABP-104, an orally-active and systemically bioavailable small molecule therapeutic candidate that targets LANCL2 agonist for the treatment of systemic lupus erythematosus and rheumatoid arthritis (RA). Its preclinical candidates in development include LABP-66 is an oral and small molecule NOD-like pathway agonist for the treatment of multiple sclerosis and Alzheimer's disease; LABP-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and RA; LABP-73, an oral and small molecule NLRX1 pathway agonist in development for the treatment of asthma and chronic obstructive pulmonary disease; and LABP-111, an oral and small molecule LANCL2 pathway agonist for the treatment of nonalcoholic steatohepatitis and type 1 diabetes. The company was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Company Information
| Employees | 19 |
| Beta | 0.14 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Landos Biopharma, Inc. (NASDAQ: LABP) stock price is $22.93 in the last trading session. During the trading session, LABP stock reached the peak price of $22.94 while $22.75 was the lowest point it dropped to. The percentage change in LABP stock occurred in the recent session was 0.57% while the dollar amount for the price change in LABP stock was $0.13.
The NASDAQ listed LABP is part of Biotechnology industry that operates in the broader Healthcare sector. Landos Biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Gregory Oakes
Pres, Chief Executive Officer & Director
Mr. Patrick Truesdell
Vice President , Controller & Principal Accounting Officer
Dr. Fabio Cataldi M.D.
Executive Vice President & Chief Medical Officer
Mr. Timothy M. Mayleben M.B.A.
Principal Financial Officer & Director
Ms. Rebecca Mosig Ph.D.
Executive Director of Corporation Devel.
Dr. Josep Bassaganya-Riera DVM, Ph.D.
Advisor
LABP's closing price is 629.09% higher than its 52-week low of $3.15 where as its distance from 52-week high of $22.94 is -0.04%.
Number of LABP employees currently stands at 19.
Official Website of LABP is: https://landosbiopharma.com
LABP could be contacted at phone 540 218 2232 and can also be accessed through its website. LABP operates from 1800 Kraft Drive, Blacksburg, VA 24060, United States.
LABP stock volume for the day was 50.9K shares. The average number of LABP shares traded daily for last 3 months was 27.04K.
The market value of LABP currently stands at $71.68M with its latest stock price at $22.93 and 3.13M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com